Mental Health App + Remote Therapy for Depression
(TREE-Connect Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you either be off antidepressants or on a stable dose for at least 8 weeks before joining, and you should not plan to change the dose during the study. If you meet these conditions, you can continue your current medication.
What data supports the effectiveness of the treatment Clinician-delivered psychotherapy, TREE-Connect for depression?
Research shows that mobile phone-based psychotherapies, including apps and text messaging, are feasible and acceptable for treating mental health disorders like depression. A study on guided Internet-delivered treatment for major depression found significant improvements in depressive symptoms, suggesting that digital and remote therapy approaches can be effective.12345
Is the Mental Health App + Remote Therapy for Depression safe for humans?
Research shows that digital mental health interventions, including those using smartphone apps, are generally safe for people with depression, even those with suicidal thoughts. These interventions are feasible and acceptable, with good retention rates, indicating they are safe for use in humans.12678
How is the TREE-Connect treatment for depression different from other treatments?
TREE-Connect is unique because it combines a mental health app with remote therapy, offering a digital and personalized approach to managing depression. This treatment leverages technology to improve access and engagement, which is particularly beneficial for those who may not have easy access to traditional therapy.19101112
What is the purpose of this trial?
This study will investigate whether an intervention that includes remotely delivered therapy sessions and a digital mental health app, compared to only remotely delivered therapy reduces late-life depression
Research Team
Nili Solomonov, PhD
Principal Investigator
Weill Medical College of Cornell University
Samprit Banerjee, PhD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for adults aged 50-80 with moderate to severe depression (PHQ-9 ≥10), a clear mental state (MMSE ≥23), and stable on antidepressants or off them. They must not be receiving other psychotherapy, have no major psychiatric diagnoses besides specific ones allowed, no recent suicidal intent, and no severe medical conditions that could affect depression or participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a hybrid intervention that includes clinician-delivered psychotherapy and the TREE-Connect app, or solely clinician-delivered psychotherapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Clinician-delivered psychotherapy
- TREE-Connect
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor